Calcitonin Stewardship Strategies

被引：2

作者：

Allison, Steven L. ^{[1
]}

Davis, Kevin W., II ^{[2
]}

机构：

[1] Florida Hosp, Pharm, Orlando, FL 32803 USA

[2] Univ Florida Hlth Jacksonville, Jacksonville, FL USA

来源：

JOURNAL OF PHARMACY PRACTICE | 2019年 / 32卷 / 05期

关键词：

calcitonin; hypercalcemia; HYPERCALCEMIA;

D O I：

10.1177/0897190018770052

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Despite being approved by the Food and Drug Administration for over 30 years, calcitonin salmon has seen a dramatic increase in acquisition cost over the last few years. Being commonly used for the treatment of hypercalcemia of malignancy, health systems must implement stewardship strategies in order to curtail usage. This review is intended to provide a background on calcitonin usage for hypercalcemia of malignancy and associated strategies to ensure appropriateness of utilization within health systems.

引用

页码：584 / 585

页数：2

共 8 条

[1] [Anonymous], 2016, MIAC INJ CALC SALM P
[2] EVIDENCE FOR CALCITONIN - A NEW HORMONE FROM PARATHYROID THAT LOWERS BLOOD CALCIUM
COPP, DH
DAVIDSON, AG
HENZE, KG
CHENEY, BA
CAMERON, EC
[J]. ENDOCRINOLOGY, 1962, 70 (05) : 638 - +
[3] Conventional treatment of hypercalcemia of malignancy
Davidson, TG
[J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (22) : S8 - S15
[4] Prevalence of hypercalcemia among cancer patients in the United States
Gastanaga, Victor M.
Schwartzberg, Lee S.
Jain, Rajul K.
Pirolli, Melissa
Quach, David
Quigley, Jane M.
Mu, George
Stryker, W. Scott
Liede, Alexander
[J]. CANCER MEDICINE, 2016, 5 (08): : 2091 - 2100
[5] Langreth R, 2016, DEALMAKERSE SOARING
[6] NORC at the University of Chicago, 2016, TRENDS HOSP INP DRUG
[7] Molecular pharmacology of the calcitonin receptor
Purdue, BW
Tilakaratne, N
Sexton, PM
[J]. RECEPTORS & CHANNELS, 2002, 8 (3-4) : 243 - 255
[8] Ziegler R, 2001, J AM SOC NEPHROL, V12, pS3

← 1 →